Table 2 Associated factors of all-cause mortality in the original cohort before IPTW.
Variable | HR (95% CI) | P |
---|---|---|
Dialysis facility level | ||
Medical center | Reference | |
Non-medical center | 1.13 (1.09–1.17) | < 0.001 |
Clinics | 1.11 (1.06–1.15) | < 0.001 |
Dialysis facility size (per 20 beds) | 0.991 (0.984–0.998) | 0.009 |
Age (per year) | 1.05 (1.05–1.05) | < 0.001 |
Male | 1.20 (1.17–1.23) | < 0.001 |
No. of nephrologist outpatient visits in the previous year | 0.987 (0.986–0.988) | < 0.001 |
Urbanization level | ||
Low | Reference | |
Moderate | 0.96 (0.92–0.99) | 0.008 |
High | 0.94 (0.91–0.98) | 0.001 |
Very High | 0.967 (0.931–1.004) | 0.081 |
Monthly income, US dollars | ||
0–593 | Reference | |
596–760 | 0.95 (0.93–0.98) | < 0.001 |
> 760 | 0.87 (0.85–0.90) | < 0.001 |
Diabetes mellitus | 1.34 (1.30–1.38) | < 0.001 |
Hypertension | 0.95 (0.92–0.98) | 0.002 |
Dyslipidemia | 0.95 (0.92–0.97) | < 0.001 |
Coronary arterial disease | 1.04 (1.02–1.07) | 0.001 |
Peripheral arterial disease | 1.05 (0.99–1.11) | 0.110 |
Chronic obstructive pulmonary disease | 1.09 (1.05–1.13) | < 0.001 |
Obstructive sleep apnea | 1.03 (0.85–1.25) | 0.769 |
Gouty arthritis | 0.92 (0.89–0.94) | < 0.001 |
Liver cirrhosis | 1.50 (1.43–1.58) | < 0.001 |
Heart failure hospitalization | 1.20 (1.17–1.23) | < 0.001 |
Ischemic stroke | 1.20 (1.16–1.23) | < 0.001 |
Hemorrhage stroke | 1.20 (1.11–1.30) | < 0.001 |
Systemic embolism | 1.29 (1.21–1.37) | < 0.001 |
Myocardial infarction | 1.15 (1.11–1.20) | < 0.001 |
Charlson comorbidity index | 1.09 (1.08–1.10) | < 0.001 |
Initial vascular access | ||
Arteriovenous fistula | Reference | |
Arteriovenous graft | 1.17 (1.13–1.21) | < 0.001 |
Tunneled cuffed catheter | 1.28 (1.24–1.31) | < 0.001 |